{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:27:07Z","timestamp":1792114027090,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2018SCU12026"],"award-info":[{"award-number":["2018SCU12026"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018T110985"],"award-info":[{"award-number":["2018T110985"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690261"],"award-info":[{"award-number":["81690261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jconrel.2019.05.019","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T02:43:00Z","timestamp":1557801780000},"page":"204-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"special_numbering":"C","title":["Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR\/Cas9 system suppressed the metastasis of pancreatic cancer"],"prefix":"10.1016","volume":"304","author":[{"given":"Man","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingli","family":"Cun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-5394","authenticated-orcid":false,"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0721-7678","authenticated-orcid":false,"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.05.019_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0010","first-page":"271","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ccell.2016.12.006","article-title":"Employing metabolism to improve the diagnosis and treatment of pancreatic Cancer","volume":"31","author":"Halbrook","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc.2016.66","article-title":"Pancreatic cancer biology and genetics from an evolutionary perspective","volume":"16","author":"Makohon-Moore","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ncb3513","article-title":"The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer","volume":"19","author":"Krebs","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0030","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nrgastro.2012.115","article-title":"The role of stroma in pancreatic cancer: diagnostic and therapeutic implications","volume":"9","author":"Erkan","year":"2012","journal-title":"Nat. Rev. Gastroenterol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/17474124.2016.1117386","article-title":"The role of hypoxia in pancreatic cancer: a potential therapeutic target?","volume":"10","author":"Erkan","year":"2016","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","article-title":"Direct regulation of TWIST by HIF-1\u03b1 promotes metastasis","volume":"10","author":"Yang","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(03)00194-6","article-title":"The hypoxic response of tumors is dependent on their microenvironment","volume":"4","author":"Blouw","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","article-title":"The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2017.09.017","article-title":"Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1\u03b1 pathway","volume":"410","author":"Yoshikawa","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2014.08.001","article-title":"Hypoxia inducible factor (HIF)-1\u03b1 directly activates leptin receptor (Ob-R) in pancreatic cancer cells","volume":"354","author":"Ren","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0065","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1021\/mp300193f","article-title":"Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth","volume":"9","author":"Xi-Qiu","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0070","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.1159689","article-title":"Small CRISPR RNAs guide antiviral defense in prokaryotes","volume":"321","author":"Stan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nbt.2842","article-title":"CRISPR-Cas systems for editing, regulating and targeting genomes","volume":"32","author":"Jeffry","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0080","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Jennifer","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0085","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/hum.2015.074","article-title":"Delivery and specificity of CRISPR-Cas9 genome editing Technologies for Human Gene Therapy","volume":"26","author":"Gori","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nbt.2800","article-title":"Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library","volume":"32","author":"Koike-Yusa","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0100","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.7b07874","article-title":"Macrophage-specific in vivo gene editing using cationic lipid-assisted polymeric nanoparticles","volume":"12","author":"Luo","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0105","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1038\/ncomms8391","article-title":"Somatic CRISPR\/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling","volume":"6","author":"Zuckermann","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0110","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1093\/nar\/27.19.3792","article-title":"Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency","volume":"27","author":"Cameron","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201700540","article-title":"HPV oncogene manipulation using nonvirally delivered CRISPR\/Cas9 or Natronobacterium gregoryi Argonaute","volume":"5","author":"Lao","year":"2018","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.mattod.2018.12.003","article-title":"Material solutions for delivery of CRISPR\/Cas-based genome editing tools: current status and future outlook","author":"Wan","year":"2019","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo","volume":"33","author":"Zuris","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2018.08.031","article-title":"In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR\/Cas9 system","volume":"288","author":"Schuh","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2017.09.012","article-title":"Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications","volume":"266","author":"Liu","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ctrv.2011.01.006","article-title":"Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside","volume":"37","author":"Yang","year":"2011","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0145","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1021\/bi9602019","article-title":"Mechanism of DNA release from cationic liposome\/DNA complexes used in cell transfection","volume":"35","author":"Xu","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0150","first-page":"500","article-title":"Dual receptor recognizing cell penetrating peptide for selective targeting, efficient Intratumoral diffusion and synthesized anti-glioma therapy","volume":"12","author":"Liu","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0155","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0160","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s00262-005-0685-2","article-title":"Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer","volume":"54","author":"Cui","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0165","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1093\/nar\/gkv226","article-title":"Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference","volume":"43","author":"Rodolphe","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.stem.2014.06.011","article-title":"Whole-genome sequencing analysis reveals high specificity of CRISPR\/Cas9 and TALEN-based genome editing in human iPSCs","volume":"15","author":"Smith","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0175","doi-asserted-by":"crossref","first-page":"12197","DOI":"10.1002\/ange.201506030","article-title":"Self-assembled DNA Nanoclews for the efficient delivery of CRISPR\u2013Cas9 for genome editing","volume":"127","author":"Sun","year":"2015","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biomaterials.2018.04.052","article-title":"Optimization of lipid-assisted nanoparticle for disturbing neutrophils-related inflammation","volume":"172","author":"Liu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800068","article-title":"Cationic polymer-mediated CRISPR\/Cas9 plasmid delivery for genome editing","volume":"40","author":"Zhang","year":"2019","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0190","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.18632\/oncotarget.14072","article-title":"Targeted delivery of CRISPR\/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome","volume":"8","author":"Zhen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0195","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","article-title":"A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing","volume":"22","author":"Finn","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acsnano.6b04261","article-title":"Artificial virus delivers CRISPR-Cas9 system for genome editing of cells in mice","volume":"11","author":"Li","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2017.09.013","article-title":"Cancer-derived exosomes as a delivery platform of CRISPR\/Cas9 confer cancer cell tropism-dependent targeting","volume":"266","author":"Kim","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0210","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature13589","article-title":"CRISPR-mediated direct mutation of cancer genes in the mouse liver","volume":"514","author":"Xue","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0215","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1128\/JVI.01879-14","article-title":"Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease","volume":"88","author":"Kennedy","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0220","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.1073\/pnas.1410785111","article-title":"RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0225","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1038\/s41467-018-06522-5","article-title":"Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0230","first-page":"1872","article-title":"HIF-1\u03b1\/IL-1\u03b2 signaling enhances hepatoma epithelial-mesenchymal transition via macrophages in a hypoxic-inflammatory microenvironment","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2009.10.009","article-title":"HIF-1: upstream and downstream of cancer metabolism","volume":"20","author":"Semenza","year":"2010","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336918.2015.1129481","article-title":"The tumor microenvironment: an irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis","volume":"10","author":"Li","year":"2016","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0245","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.canlet.2014.11.034","article-title":"The HIF-1\u03b1\/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells","volume":"357","author":"Guan","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2017.06.001","article-title":"Feedback regulation of ALDOA activates the HIF-1\u03b1\/MMP9 axis to promote lung cancer progression","volume":"403","author":"Chang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0255","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41467-017-01947-w","article-title":"Parkin targets HIF-1\u03b1 for ubiquitination and degradation to inhibit breast tumor progression","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2014.12.028","article-title":"Co-delivery of HIF1\u03b1 siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer","volume":"46","author":"Zhao","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.05.019_bb0265","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","article-title":"Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models","volume":"21","author":"Keklikoglou","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2019.05.019_bb0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo","volume":"33","author":"Zuris","year":"2014","journal-title":"Nat. Biotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919302676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919302676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:42:42Z","timestamp":1778730162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919302676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":54,"alternative-id":["S0168365919302676"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.05.019","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR\/Cas9 system suppressed the metastasis of pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}